CLICK HERE TO LEARN MORE OR REGISTER | Live Webinar + On-Demand Course Access
In recent years, psychedelics have been gaining popularity when it comes to treating an array of mental health issues. With its promising medical and therapeutic benefits, psychedelic-assisted psychotherapy (PAP) is generating significant interest among policymakers, medical professionals, and the public. As it provides an alternative treatment for refractory mental health concerns, several cities in the U.S are starting to decriminalize some psychedelics.
However, the Food and Drug Administration’s (FDA) approval for psychedelic treatment is still tough. As legal challenges and the upswing of studies in this field are likely to emerge, companies and practitioners must stay in the loop.
In a LIVE Webcast, a panel of key thought leaders and practitioners will offer an in-depth discussion of psychedelic-assisted therapy. Speakers will also dig deep into its potential opportunities, risks and pitfalls, and legal developments.
Key issues that will be covered in this course are:
- Psychedelic Therapy: Nuts and Bolts
- Potential Opportunities of Psychedelics
- New Shifts in Psychedelic Drug Policies in the U.S.
- Emerging Legal Challenges
- What Lies Ahead?